Imaging of the brain in patient

Topics in Magnetic Resonance Imaging

Volumn 23, Issue 5, 2014, Pages 275-291

  Gottumukkala, Ravi V ^a   Romero, Javier M ^b   Riascos, Roy F ^c   Rojas, Rafael ^b   Glikstein, Rafael S ^d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

^d University of Ottawa   (United States)

Author keywords

AIDS; Brain; Central nervous system; HIV; Imaging; Magnetic resonance imaging; Neuroimaging; Neurologic; Opportunistic infection

Indexed keywords

EFALIZUMAB; NATALIZUMAB; RITUXIMAB;

AIDS PATIENT; BLOOD BRAIN BARRIER; BRAIN CIRCULUS ARTERIOSUS; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL SWELLING; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTION; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS ENCEPHALITIS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSION TENSOR IMAGING; FRACTIONAL ANISOTROPY; GLIOMA; HERPES SIMPLEX VIRUS 1; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCEPHALUS; IMMUNOSUPPRESSIVE TREATMENT; INTRACRANIAL TUBERCULOMA; LABORATORY TEST; LONG TERM CARE; MENINGIOMA; MIDDLE CEREBELLAR PEDUNCLE; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROSYPHILIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; TOXOPLASMA GONDII; TOXOPLASMOSIS; TREPONEMA PALLIDUM; VIRUS LOAD; WHITE MATTER; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CENTRAL NERVOUS SYSTEM INFECTIONS; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; PROCEDURES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CENTRAL NERVOUS SYSTEM INFECTIONS; FEMALE; HIV-1; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROIMAGING; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84930175979     PISSN: 08993459     EISSN: 15361004     Source Type: Journal    
DOI: 10.1097/RMR.0000000000000031     Document Type: Review

References (127)

1. UNAIDS/WHO. UNAIDS Report on the Global AIDS Epidemic 2013. 2013.
2. The Center for Disease Control. HIV in the United States: At A Glance. 2013.
3. Levy RM, Bredesen DE, Rosenblum ML. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg. 1985;62:475-495.
4. González-Scarano F, Martín-García J. The neuropathogenesis of AIDS. Nat Rev Immunol. 2005;5:69-81.
5. Budka H, Wiley CA, Kleihues P, et al. HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol. 1991;1:143-152.
6. Ances BM, Ellis RJ. Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol. 2007;27:86-92.
7. McArthur JC, Haughey N, Gartner S, et al. Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol. 2003;9: 205-221.
8. Bhaskaran K, Mussini C, Antinori A, et al. Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann Neurol. 2008;63: 213-221.
9. Smith AB, Smirniotopoulos JG, Rushing EJ. From the archives of the AFIP: central nervous system infections associated with human immunodeficiency virus infection: radiologic-pathologic correlation. Radiographics. 2008;28:2033-2058.
10. Ciardi A, Sinclair E, Scaravilli F, et al. The involvement of the cerebral cortex in human immunodeficiency virus encephalopathy: a morphological and immunohistochemical study. Acta Neuropathol. 1990;81:51-59.
11. Kim DM, TienR,Byrum C, et al. Imaging inacquired immune deficiency syndrome dementia complex (AIDS dementia complex): a review. Prog Neuropsychopharmacol Biol Psychiatry. 1996;20:349-370.
12. Post MJ, Tate LG, Quencer RM, et al. CT, MR, and pathology in HIV encephalitis and meningitis. AJR Am J Roentgenol. 1988;151:373-380.
13. Broderick DF, Wippold FJ, Clifford DB, et al. White matter lesions and cerebral atrophy on MR images in patients with and without AIDS dementia complex. AJR Am J Roentgenol. 1993;161:177-181.
14. Olsen WL, Longo FM, Mills CM, et al. White matter disease in AIDS: findings at MR imaging. Radiology. 1988;169:445-448.
15. Dal Pan GJ, McArthur JH, Aylward E,et al. Patterns ofcerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis. Neurology. 1992;42:2125-2130.
16. Hestad K, McArthur JH, Dal Pan GJ, et al. Regional brain atrophy in HIV-1 infection: association with specific neuropsychological test performance. Acta Neurol Scand. 1993;88:112-118.
17. Thurnher MM, Schindler EG, Thurnher SA, et al. Highly active antiretroviral therapy for patients with AIDS dementia complex: effect on MR imaging findings and clinical course. AJNR Am J Neuroradiol. 2000;21:670-678.
18. Laubenberger J, Häussinger D, Bayer S, et al. HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. Radiology. 1996;199:805-810.
19. Chang L, Ernst T, Leonido-Yee M, et al. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology. 1999;52:100-108.
20. Suwanwelaa N, Phanuphak P, Phanthumchinda K, et al. Magnetic resonance spectroscopy of the brain in neurologically asymptomatic HIV-infected patients. Magn Reson Imaging. 2000;18:859-865.
21. Pomara N, Crandall DT, Choi SJ, et al. White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study. Psychiatry Res. 2001; 106:15-24.
22. Filippi CG, Ulug AM, Ryan E, et al. Diffusion tensor imaging of patients with HIVand normal-appearing white matter on MR images of the brain. AJNR Am J Neuroradiol. 2001;22:277-283.
23. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363: 1965-1976.
24. Mathews WC, Fullerton SC. Use of a clinical laboratory database to estimate Toxoplasma seroprevalence among human immunodeficiency virus-infected patients. Overcoming bias in secondary analysis of clinical records. Arch Pathol Lab Med. 1994;118:807-810.
25. Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis. 1992;15:211-222.
26. Antinori A, Larussa D, Cingolani A, et al. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy. Clin Infect Dis. 2004;39:1681-1691.
27. Antinori A, Ammassari A, De Luca A, et al. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology. 1997;48:687-694.
28. Cingolani A, De Luca A, Ammassari A, et al. PCR detection of Toxoplasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions. J Med Microbiol. 1996;45:472-476.
29. Colombo FA, Vidal JE, Penalva de Oliveira AC, et al. Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: importance of molecular and immunological methods using peripheral blood samples. J Clin Microbiol. 2005;43:5044-5047.
30. Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. NEngl J Med. 1992;327: 1643-1648.
31. Navia BA, Petito CK, Gold JW, et al. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol. 1986;19:224-238.
32. Mahadevan A, Ramalingaiah AH, Parthasarathy S, et al. Neuropathological correlate of the "concentric target sign" in MRI of HIV-associated cerebral toxoplasmosis. JMagn Reson Imaging. 2013;38:488-495.
33. Evaluation and management of intracranial mass lesions in AIDS. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 1998;50:21-26.
34. Dina TS. Primary central nervous system lymphoma versus toxoplasmosis in AIDS. Radiology. 1991;179:823-828.
35. Post MJ, Sheldon JJ, Hensley GT, et al. Central nervous system disease in acquired immunodeficiency syndrome: prospective correlation using CT, MR imaging, and pathologic studies. Radiology. 1986;158:141-148.
36. Bhagavati S, Choi J. Frequent hemorrhagic lesions in cerebral toxoplasmosis in AIDS patients. JNeuroimaging. 2009;19:169-173.
37. Revel MP, Gray F, Brugieres P, et al. Hyperdense CT foci in treated AIDS toxoplasmosis encephalitis: MR and pathologic correlation. J Comput Assist Tomogr. 16:372-375.
38. Thurnher MM, Donovan Post MJ. Neuroimaging in the brain in HIV-1-infected patients. Neuroimaging Clin NAm. 2008;18:93-117; viii.
39. Brightbill TC, Post MJ, Hensley GT, et al. MR ofToxoplasma encephalitis: signal characteristics on T2-weighted images and pathologic correlation. J Comput Assist Tomogr. 20:417-422.
40. Kumar GGS, Mahadevan A, Guruprasad AS, et al. Eccentric target sign in cerebral toxoplasmosis: neuropathological correlate to the imaging feature. JMagn Reson Imaging. 2010;31:1469-1472.
41. Skiest DJ, Erdman W, Chang WE, et al. SPECT thallium-201 combined with Toxoplasma serology for the presumptive diagnosis of focal central nervous system mass lesions in patients with AIDS. J Infect. 2000;40: 274-281.
42. Lorberboym M, Wallach F, Estok L, et al. Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and nonmalignant lesions in AIDS patients. JNuclMed. 1998;39:1366-1369.
43. Hoffman JM, Waskin HA, Schifter T, et al. FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. JNucl Med. 1993;34:567-575.
44. Chinn RJ, Wilkinson ID, Hall-Craggs MA, et al. Toxoplasmosis and primary central nervous system lymphoma in HIV infection: diagnosis with MR spectroscopy. Radiology. 1995;197:649-654.
45. Camacho DLA, Smith JK, Castillo M. Differentiation of toxoplasmosis and lymphoma in AIDS patients by using apparent diffusion coefficients. AJNRAm JNeuroradiol. 2003;24:633-637.
46. Schroeder PC, Post MJD, Oschatz E, et al. Analysis of the utility of diffusion-weighted MRI and apparent diffusion coefficient values in distinguishing central nervous system toxoplasmosis from lymphoma. Neuroradiology. 2006;48:715-720.
47. Ernst TM, Chang L, Witt MD, et al. Cerebral toxoplasmosis and lymphoma in AIDS: perfusion MR imaging experience in 13 patients. Radiology. 1998;208:663-669.
48. Arribas JR, Storch GA, Clifford DB, et al. Cytomegalovirus encephalitis. Ann Intern Med. 1996;125:577-587.
49. Bylsma SS, Achim CL, Wiley CA, et al. The predictive value of cytomegalovirus retinitis for cytomegalovirus encephalitis in acquired immunodeficiency syndrome. Arch Ophthalmol. 1995;113:89-95.
50. Kalayjian RC, Cohen ML, Bonomo RA, et al. Cytomegalovirus ventriculoencephalitis in AIDS. A syndrome with distinct clinical and pathologic features. Medicine (Baltimore). 1993;72:67-77.
51. Holland NR, Power C, Mathews VP, et al. Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS). Neurology. 1994;44(3 Pt 1):507-514.
52. Berman SM, Kim RC. The development of cytomegalovirus encephalitis in AIDS patients receiving ganciclovir. Am J Med. 1994;96:415-419.
53. Morgello S, Cho ES, Nielsen S, et al. Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: an autopsy study of 30 cases and a review of the literature. Hum Pathol. 1987;18:289-297.
54. Post MJ, Hensley GT, Moskowitz LB, et al. Cytomegalic inclusion virus encephalitis in patients with AIDS: CT, clinical, and pathologic correlation. AJR Am J Roentgenol. 1986;146:1229-1234.
55. Seok JH, Ahn K, Park HJ. Diffusion MRI findings of cytomegalovirus-associated ventriculitis: a case report. Br J Radiol. 2011; 84:e179-e181.
56. Clifford DB, Arribas JR, Storch GA, et al. Magnetic resonance brain imaging lacks sensitivity for AIDS associated cytomegalovirus encephalitis. J Neurovirol. 1996;2:397-403.
57. Dyer JR, French MA, Mallal SA. Cerebral mass lesions due to cytomegalovirus in patients with AIDS: report of two cases. J Infect. 1995; 30:147-151.
58. Wilkinson ID, Miller RF, Paley MN, et al. Cerebral proton magnetic resonance spectroscopy in cytomegalovirus encephalitis and HIV leucoencephalopathy/encephalitis. AIDS. 1996;10:1443-1444.
59. Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol. 2010;9:425-437.
60. Brew BJ, Davies NWS, Cinque P, et al. Progressive multifocal leukoencephalopathy and other forms ofJC virus disease. Nat Rev Neurol. 2010;6:667-679.
61. White MK, Khalili K. Pathogenesis of progressive multifocal leukoencephalopathy-revisited. J Infect Dis. 2011;203:578-586.
62. Cinque P, Koralnik IJ, Gerevini S, et al. Progressive multifocal leukoencephalopathy in HIV-1 infection. Lancet Infect Dis. 2009;9:625-636.
63. Marzocchetti A, Di Giambenedetto S, Cingolani A, et al. Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy. J Clin Microbiol. 2005;43: 4175-4177.
64. Tan K,Roda R, Ostrow L,et al. PML-IRISin patients with HIV infection: clinical manifestations and treatment with steroids. Neurology. 2009;72: 1458-1464.
65. Berger JR, Aksamit AJ, Clifford DB, et al. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology. 2013;80:1430-1438.
66. Berger JR, Pall L, Lanska D, et al. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol. 1998;4:59-68.
67. Whiteman ML, Post MJ, Berger JR, et al. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology. 1993;187:233-240.
68. Shah R, Bag AK, Chapman PR, et al. Imaging manifestations of progressive multifocal leukoencephalopathy. Clin Radiol. 2010;65: 431-439.
69. Sahraian MA, Radue E-W, Eshaghi A, et al. Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis. Eur J Neurol. 2012;19:1060-1069.
70. Berger JR, Levy RM, Flomenhoft D, et al. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol. 1998;44:341-349.
71. Yousry TA, Pelletier D, Cadavid D, et al. Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol. 2012;72:779-787.
72. Bergui M, Bradac GB, Oguz KK, et al. Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations. Neuroradiology. 2004;46:22-25.
73. Usiskin SI, Bainbridge A, Miller RF, et al. Progressive multifocal leukoencephalopathy: serial high-b-value diffusion-weighted MR imaging and apparent diffusion coefficient measurements to assess response to highly active antiretroviral therapy. AJNR Am JNeuroradiol. 2007;28:285-286.
74. Buckle C, Castillo M. Use of diffusion-weighted imaging to evaluate the initial response of progressive multifocal leukoencephalopathy to highly active antiretroviral therapy: early experience. AJNR Am J Neuroradiol. 2010;31:1031-1035.
75. Ernst T, Chang L, Witt M, et al. Progressive multifocal leukoencephalopathy and human immunodeficiency virus-associated white matter lesions in AIDS: magnetization transfer MR imaging. Radiology. 1999;210:539-543.
76. Whiteman M, Espinoza L, Post MJ, et al. Central nervous system tuberculosis in HIV-infected patients: clinical and radiographic findings. AJNR Am J Neuroradiol. 16:1319-1327.
77. Thwaites GE, Tran TH. Tuberculous meningitis: many questions, too few answers. Lancet Neurol. 2005;4:160-170.
78. Sepkowitz KA, Raffalli J, Riley L, et al. Tuberculosis in the AIDS era. Clin Microbiol Rev. 1995;8:180-199.
79. Donald PR, Schoeman JF. Tuberculous meningitis. N Engl J Med. 2004; 351:1719-1720.
80. Trivedi R, Saksena S, Gupta RK. Magnetic resonance imaging in central nervous system tuberculosis. Indian J Radiol Imaging. 2009;19:256-265.
81. Villoria MF, de la Torre J, Fortea F, et al. Intracranial tuberculosis in AIDS: CT and MRI findings. Neuroradiology. 1992;34:11-14.
82. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004;351:1741-1751.
83. Rock RB, Olin M, Baker CA, et al. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev. 2008;21:243-261.
84. Katrak SM, Shembalkar PK, Bijwe SR, et al. The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection. J Neurol Sci. 2000;181:118-126.
85. Salgado P, Del Brutto OH, Talamás O, et al. Intracranial tuberculoma: MR imaging. Neuroradiology. 1989;31:299-302.
86. Bargalló J, Berenguer J, García-Barrionuevo J, et al. The "target sign": is it a specific sign of CNS tuberculoma? Neuroradiology 1996;38: 547-550.
87. Burrill J, Williams CJ, Bain G, et al. Tuberculosis: a radiologic review. Radiographics. 2007;27:1255-1273.
88. Bernaerts A, Vanhoenacker FM, Parizel PM, et al. Tuberculosis of the central nervous system: overview of neuroradiological findings. Eur Radiol. 2003;13:1876-1890.
89. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev. 1995;8:515-548.
90. Jarvis JN, Harrison TS. HIV-associated cryptococcal meningitis. AIDS. 2007;21:2119-2129.
91. Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:291-322.
92. Shelburne SA, Darcourt J, White AC, et al. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40:1049-1052.
93. Haddow LJ, Colebunders R, Meintjes G, et al. Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis. 2010;10:791-802.
94. Lee SC, Dickson DW, Casadevall A. Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications. Hum Pathol. 1996;27:839-847.
95. Arnder L, Castillo M, Heinz ER, et al. Unusual pattern of enhancement in cryptococcal meningitis: in vivo findings with postmortem correlation. J Comput Assist Tomogr. 20:1023-1026.
96. Klock C, Cerski M, Goldani LZ. Histopathological aspects of neurocryptococcosis in HIV-infected patients: autopsy report of 45 patients. Int J Surg Pathol. 2009;17:444-448.
97. Hospenthal DR, Bennett JE. Persistence of cryptococcomas on neuroimaging. Clin Infect Dis. 2000;31:1303-1306.
98. Ruiz A, Post MJ, Bundschu CC. Dentate nuclei involvement in AIDS patients with CNS cryptococcosis: imaging findings with pathologic correlation. J Comput Assist Tomogr. 21:175-182.
99. Charlier C, Dromer F, Lévêque C, et al. Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era. PLoS One. 2008;3:e1950.
100. Tien RD, Chu PK, Hesselink JR, et al. Intracranial cryptococcosis in immunocompromised patients: CTand MR findings in 29 cases. AJNR Am J Neuroradiol. 12:283-289.
101. Cornell SH, Jacoby CG. The varied computed tomographic appearance of intracranial cryptococcosis. Radiology. 1982;143:703-707.
102. Popovich MJ, Arthur RH, Helmer E. CTof intracranial cryptococcosis. AJNR Am J Neuroradiol. 11:139-142.
103. Miszkiel KA, Hall-Craggs MA, Miller RF, et al. The spectrum of MRI findings in CNS cryptococcosis in AIDS. Clin Radiol. 1996;51:842-850.
104. Wehn SM, Heinz ER, Burger PC, et al. Dilated Virchow-Robin spaces in cryptococcal meningitis associated with AIDS: CTand MR findings. J Comput Assist Tomogr. 1989;13:756-762.
105. Andreula CF, Burdi N, Carella A. CNS cryptococcosis inAIDS: spectrum of MR findings. J Comput Assist Tomogr. 1993;17:438-441.
106. Li Q, You C, Liu Q, et al. Central nervous system cryptococcoma in immunocompetent patients: a short review illustrated by a new case. Acta Neurochir (Wien)h. 2010;152:129-136.
107. Vender JR, Miller DM, Roth T, et al. Intraventricular cryptococcal cysts. AJNR Am J Neuroradiol. 1996;17:110-113.
108. Lukehart SA, Hook EW, Baker-Zander SA, et al. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med. 1988;109:855-862.
109. Clark EG, Danbolt N. The Oslo study of the natural history of untreated syphilis; an epidemiologic investigation based on a restudy of the Boeck-Bruusgaard material; a review and appraisal. J Chronic Dis. 1955;2:311-344.
110. The Center for Disease Control. Neurosyphilis among HIV-positive men who have sex with men-four cities, United States, January 2002-June 2004. JAMA. 2007;298:7-9.
111. Johns DR, Tierney M, Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med. 1987;316:1569-1572.
112. Katz DA, Berger JR, Duncan RC. Neurosyphilis. A comparative study of the effects of infection with human immunodeficiency virus. Arch Neurol. 1993;50:243-249.
113. De Souza MC, Nitrini R. Effects of human immunodeficiency virus infection on the manifestations of neurosyphilis. Neurology. 1997;49: 893-894.
114. Gitaí LLG, Jaláli PS, Takayanagui OM. Neurosyphilis in the age ofAIDS: clinical and laboratory features. Neurol Sci. 2009;30:465-470.
115. Brightbill TC, Ihmeidan IH, Post MJ, et al. Neurosyphilis in HIV-positive and HIV-negative patients: neuroimaging findings. AJNR Am J Neuroradiol. 1995;16:703-711.
116. Yachnis AT, Rivera-Zengotita ML. Neuropathology: A Volume in the High Yield Pathology Series. 1st ed. Philadelphia: Saunders/Elsevier; 2013:206.
117. Tien RD, Gean-Marton AD, Mark AS. Neurosyphilis in HIV carriers: MR findings in six patients. AJR Am J Roentgenol. 1992; 158:1325-1328.
118. Holland BA, Perrett LV, Mills CM. Meningovascular syphilis: CT and MR findings. Radiology. 1986;158:439-442.
119. Ances BM, Danish SF, Kolson DL, et al. Cerebral gumma mimicking glioblastoma multiforme. Neurocrit Care. 2005;2:300-302.
120. Bash S, Hathout GM, Cohen S. Mesiotemporal T2-weighted hyperintensity: neurosyphilis mimicking herpes encephalitis. AJNR Am J Neuroradiol. 2001;22:314-316.
121. Cohen WA. Intracranial bacterial infections in patients with AIDS. Neuroimaging Clin N Am. 1997;7:223-229.
122. Tan S V, Guiloff RJ, Scaravilli F, et al. Herpes simplex type 1 encephalitis in acquired immunodeficiency syndrome. Ann Neurol. 1993;34:619-622.
123. Chrétien F, Bélec L, Hilton DA, et al. Herpes simplex virus type 1 encephalitis in acquired immunodeficiency syndrome. Neuropathol Appl Neurobiol. 1996;22:394-404.
124. Sibtain N, Chinn R. Imaging of the central nervous system in HIV infection. Imaging. 2002;14:48-59.
125. Petito CK, Cho ES, Lemann W, et al. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol. 1986;45:635-646.
126. Gray F, Mohr M, Rozenberg F, et al. Varicella-zoster virus encephalitis in acquired immunodeficiency syndrome: report of four cases. Neuropathol Appl Neurobiol. 1992;18:502-514.
127. Toledo PV, Pellegrino LN, Cunha CA. Varicella-zoster virus encephalitis in an AIDS patient. Braz J Infect Dis. 2004;8:255-258.